Consequat non maximus dapibus egestas dictum vestibulum sociosqu. Finibus gravida suspendisse sed maecenas pretium eget volutpat. Tristique venenatis class arcu mus congue. Platea nascetur ad leo nullam mauris laoreet sagittis cubilia sapien fermentum iaculis. Odio orci et arcu curabitur ligula sapien augue turpis semper.
Lobortis nulla faucibus efficitur aliquet libero vehicula posuere neque quisque lectus magnis. Diam dictumst nam taciti ridiculus ligula interdum sodales. Curae netus dolor aliquam semper fames commodo fermentum. Rutrum fermentum vitae etiam hendrerit sapien nulla sociosqu malesuada. Odio quam semper posuere rhoncus taciti porttitor molestie. Vivamus interdum vulputate sapien dui montes est curae. Dictum duis tincidunt sociosqu urna per vestibulum.
GLP-1s, such as Semaglutide and Tirzepatide, offer a new way to treat obesity. They are classified as GLP-1 Receptor Agonists and Incretin Mimetics, first approved in 2017 for blood sugar control in Type 2 Diabetes.
GLP-1s such as Semaglutide and Tirzepatide help control blood sugar and promote weight loss. They work by slowing down how fast food leaves the stomach and reducing glucagon levels, which lowers hunger and leads to eating less, resulting in weight loss.
GLP-1 medications like Semaglutide and Tirzepatide are very effective in clinical studies. They work by activating the same receptors as natural GLP-1 hormones, improving metabolism, controlling digestion, increasing feelings of fullness, and boosting nutrient absorption.
Administer as a weekly subcutaneous injection in the abdomen, alternating sites. Start with a low dose and gradually increase, following the medical team’s dosing schedule.
No, GLP-1s like Semaglutide and Tirzepatide are not insulin or a substitute. They stimulate insulin release but are not suitable for type 1 diabetes, which requires supervision from a medical provider for insulin regulation.
No, GLP-1s like Semaglutide and Tirzepatide are not stimulants and do not cause addiction. They can be taken with appetite suppressants such as phentermine or phendimetrazine.
GLP-1s such as Semaglutide and Tirzepatide may reduce appetite by slowing gastric emptying and affecting appetite regulation through GLP-1.
Semaglutide and Tirzepatide are not covered for non-diabetics.
Phentermine is a popular prescription medication that helps reduce appetite and lose weight. It may have some minor side effects, but taking it daily can support your weight loss efforts.
The exact mechanism of phentermine, like many weight-regulating drugs, is unknown. It is believed to act on the hypothalamus, controlling hunger and arousal. The medication alters neurotransmitter activity in this area, significantly lowering appetite and aiding weight loss. Phentermine is not recommended for individuals with hypertension or kidney disease due to associated risks.
The most common side effect of phentermine is dry mouth, which can be eased by drinking plenty of water or chewing sugar-free gum. Other side effects include trouble sleeping and anxiety, which may disrupt sleep patterns and cause mood changes. These effects usually lessen as the body adjusts to the medication. Some people may also experience constipation or diarrhea when they first start taking it.
